Sex-Specific Dysconnective Brain Injuries and Neuropsychiatric Conditions such as Autism Spectrum Disorder Caused by Group B Streptococcus-Induced Chorioamnionitis
- PMID: 37762401
- PMCID: PMC10531534
- DOI: 10.3390/ijms241814090
Sex-Specific Dysconnective Brain Injuries and Neuropsychiatric Conditions such as Autism Spectrum Disorder Caused by Group B Streptococcus-Induced Chorioamnionitis
Abstract
Global health efforts have increased against infectious diseases, but issues persist with pathogens like Group B Streptococcus (GBS). Preclinical studies have elaborated on the mechanistic process of GBS-induced chorioamnionitis and its impact on the fetal programming of chronic neuropsychiatric diseases. GBS inoculation in rodents demonstrated the following: (i) silent and self-limited placental infection, similar to human chorioamnionitis; (ii) placental expression of chemokines attracting polymorphonuclear (PMN) cells; (iii) in vitro cytokine production; (iv) PMN infiltration in the placenta (histologic hallmark of human chorioamnionitis), linked to neurobehavioral impairments like cerebral palsy and autism spectrum disorders (ASD); (v) upregulation of interleukin-1β (IL-1β) in the placenta and fetal blood, associated with higher ASD risk in humans; (vi) sex-specific effects, with higher IL-1β release and PMN recruitment in male placenta; (vii) male offspring exhibiting ASD-like traits, while female offspring displayed attention deficit and hyperactivity disorder (ADHD)-like traits; (viii) IL-1 and/or NF-kB blockade alleviate placental and fetal inflammation, as well as subsequent neurobehavioral impairments. These findings offer potential therapeutic avenues, including sex-adapted anti-inflammatory treatment (e.g., blocking IL-1; repurposing of FDA-approved IL-1 receptor antagonist (IL-1Ra) treatment). Blocking the IL-1 pathway offers therapeutic potential to alleviate chorioamnionitis-related disabilities, presenting an opportunity for a human phase II RCT that uses IL-1 blockade added to the classic antibiotic treatment of chorioamnionitis.
Keywords: IL-1; androgen; autism spectrum disorder; behavioral deficits; brain injury; chorioamnionitis; fetal inflammatory response syndrome; interleukin-1 receptor antagonist; polymorphonuclear cells; preterm birth.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
IL-1 Blockade Mitigates Autism and Cerebral Palsy Traits in Offspring In-Utero Exposed to Group B Streptococcus Chorioamnionitis.Int J Mol Sci. 2024 Oct 23;25(21):11393. doi: 10.3390/ijms252111393. Int J Mol Sci. 2024. PMID: 39518945 Free PMC article.
-
Protective Effects of Interleukin-1 Blockade on Group B Streptococcus-Induced Chorioamnionitis and Subsequent Neurobehavioral Impairments of the Offspring.Front Endocrinol (Lausanne). 2022 Jul 1;13:833121. doi: 10.3389/fendo.2022.833121. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35846278 Free PMC article.
-
C-section of Preclinical Animal Model of Chorioamnionitis Triggered by Group B Streptococcus (GBS).J Vis Exp. 2021 Dec 29;(178). doi: 10.3791/63221. J Vis Exp. 2021. PMID: 35037652
-
Exposure to Group B Streptococcus-induced chorioamnionitis alters the proteome of placental extracellular vesicles.Placenta. 2025 Jan 22:S0143-4004(25)00018-9. doi: 10.1016/j.placenta.2025.01.008. Online ahead of print. Placenta. 2025. PMID: 39864996 Review.
-
Chorioamnionitis, IL-17A, and fetal origins of neurologic disease.Am J Reprod Immunol. 2018 May;79(5):e12803. doi: 10.1111/aji.12803. Epub 2017 Dec 22. Am J Reprod Immunol. 2018. PMID: 29271527 Free PMC article. Review.
Cited by
-
A bibliometric analysis of autism spectrum disorder signaling pathways research in the past decade.Front Psychiatry. 2024 Feb 12;15:1304916. doi: 10.3389/fpsyt.2024.1304916. eCollection 2024. Front Psychiatry. 2024. PMID: 38410675 Free PMC article.
-
Bioenergetic and Inflammatory Alterations in Regressed and Non-Regressed Patients with Autism Spectrum Disorder.Int J Mol Sci. 2024 Jul 27;25(15):8211. doi: 10.3390/ijms25158211. Int J Mol Sci. 2024. PMID: 39125780 Free PMC article.
-
IL-1 Blockade Mitigates Autism and Cerebral Palsy Traits in Offspring In-Utero Exposed to Group B Streptococcus Chorioamnionitis.Int J Mol Sci. 2024 Oct 23;25(21):11393. doi: 10.3390/ijms252111393. Int J Mol Sci. 2024. PMID: 39518945 Free PMC article.
-
Group B Streptococcus disease during infancy and risk of subsequent neurodevelopmental impairments in young children: a population-based cohort study in Ontario, Canada.Lancet Reg Health Am. 2025 Jul 2;48:101170. doi: 10.1016/j.lana.2025.101170. eCollection 2025 Aug. Lancet Reg Health Am. 2025. PMID: 40688764 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical